 Interpace Diagnostics Group NASDAQ:IDXG was upgraded by research analysts at ValuEngine from a buy rating to a strong-buy rating in a research report issued on Wednesday, ValuEngine reports. Several other analysts have also commented on the stock. HC Wainwright lowered their price objective on shares of Interpace Diagnostics Group from 15.00 to 12.00 and set ... 